SCHEMBL7370528

SCHEMBL7370528

NC(=O)c1nccn1CCCNC(=O)[CH]Cc1ccc(OCc2ccccc2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
QPCT Q16769 2/20 0.42
PARP10 Q53GL7 1/20 0.41
DRD2 P14416 1/20 0.41
DRD3 P35462 1/20 0.41
HDAC3 O15379 1/20 0.39
HDAC4 P56524 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC7 Q8WUI4 1/20 0.39
HDAC2 Q92769 1/20 0.39
HDAC10 Q969S8 1/20 0.39
HDAC11 Q96DB2 1/20 0.39
HDAC8 Q9BY41 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
HDAC9 Q9UKV0 1/20 0.39
HDAC5 Q9UQL6 1/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
HTT P42858 2/20 0.39
TDP1 Q9NUW8 1/20 0.39
NPC1 O15118 4/20 0.39
RAB9A P51151 4/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8191915 0.75 NPC1 (0.44) DRD2DRD3L3MBTL1HTTNPC1
SCHEMBL8189085 0.74 SIRT2 (0.47) PARP10ALDH1A1SIRT2
SCHEMBL7369224 0.72 QPCT (0.54) QPCTL3MBTL1HTTTDP1SMN1; SMN2
SCHEMBL7371153 0.70 SPHK1 (0.57) HDAC3HDAC1HDAC2HTTNPC1
SCHEMBL6030537 0.70 ALDH1A1 (0.44) ALDH1A1LMNA
SCHEMBL7341840 0.70 SPHK1 (0.54) HDAC3HDAC1HDAC2HTTNPC1
SCHEMBL3462801 0.69 NPC1 (0.54) PARP10NPC1RAB9ACASP3SENP8
SCHEMBL7405693 0.69 MAOB (0.54) NPC1RAB9AALDH1A1LMNA
SCHEMBL7404529 0.69 NPC1 (0.43) PARP10DRD2DRD3NPC1RAB9A
SCHEMBL6167127 0.67 TAAR1 (0.48) L3MBTL1HTTSMN1; SMN2KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6117841-A USED TO TREAT STROKE, CEREBRAL ISCHEMIA, PAIN, HEAD TRAUMA OR EPILEPSY WARNER-LAMBERT COMPANY (US) 2000-09-12 US claimed
WO-1998054123-A1 SUBSTITUTED PEPTIDYLAMINE CALCIUM CHANNEL BLOCKERS WARNER-LAMBERT COMPANY (US) 1998-12-03 WO claimed
US-6117841-A USED TO TREAT STROKE, CEREBRAL ISCHEMIA, PAIN, HEAD TRAUMA OR EPILEPSY WARNER-LAMBERT COMPANY (US) 2000-09-12 US disclosed
WO-1998054123-A1 SUBSTITUTED PEPTIDYLAMINE CALCIUM CHANNEL BLOCKERS WARNER-LAMBERT COMPANY (US) 1998-12-03 WO disclosed